Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR9699] to EG-VEGF
- Suitable for: WB, Flow Cyt
- Reacts with: Mouse, Human
Product nameAnti-EG-VEGF antibody [EPR9699]
See all EG-VEGF primary antibodies
DescriptionRabbit monoclonal [EPR9699] to EG-VEGF
Tested applicationsSuitable for: WB, Flow Cytmore details
Unsuitable for: ICC,IHC-P or IP
Species reactivityReacts with: Mouse, Human
Synthetic peptide within Human EG-VEGF aa 50-150 (C terminal). The exact sequence is proprietary.
(Peptide available as
- Raw 264.7, NIH/3T3, and ECV-304 cell lysates; NIH/3T3 cells.
Rat: We have preliminary internal testing data to indicate this antibody may not react with this species. Please contact us for more information.
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid repeated freeze / thaw cycles.
Storage bufferPreservative: 0.01% Sodium azide
Constituents: 9% PBS, 40% Glycerol, 0.05% BSA, 50% Tissue culture supernatant
Concentration information loading...
PurityTissue culture supernatant
Our Abpromise guarantee covers the use of ab150375 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/1000 - 1/10000. Predicted molecular weight: 12 kDa.|
|Flow Cyt||1/10 - 1/100.
ab172730 - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.
FunctionPotently contracts gastrointestinal (GI) smooth muscle. Induces proliferation, migration and fenestration (the formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. Has little or no effect on a variety of other endothelial and non-endothelial cell types. Induces proliferation and differentiation, but not migration, of enteric neural crest cells. Directly influences neuroblastoma progression by promoting the proliferation and migration of neuroblastoma cells. Positively regulates PTGS2 expression and prostaglandin synthesis. May play a role in placentation. May play a role in normal and pathological testis angiogenesis.
Tissue specificityLocalizes to glandular epithelium, stroma and vascular epithelial cells of first trimester decidua (at protein level). Up-regulated in first trimester decidua when compared with non-pregnant endometrium. Expressed in the steroidogenic glands, ovary, testis, adrenal and placenta.
Sequence similaritiesBelongs to the AVIT (prokineticin) family.
Developmental stageIn adult testis, is strongly expressed only in Leydig cells. In testicular tumors, expressed specifically in Leydig cell tumors (at protein level). Expressed from 14 weeks until birth in fetal testis.
- Information by UniProt
- Black mamba toxin related protein antibody
- EG VEGF antibody
- EG-VEGF antibody
All lanes : Anti-EG-VEGF antibody [EPR9699] (ab150375) at 1/1000 dilution
Lane 1 : Raw 264.7 cell lysate.
Lane 2 : NIH/3T3 cell lysate.
Lane 3 : ECV-304 cell lysate.
Lysates/proteins at 10 µg per lane.
All lanes : HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 12 kDa
Flow cytometric analysis of permeabilized NIH/3T3 cells labelling EG-VEGF with ab150375 at 1/10 dilution (red) or a Rabbit IgG (negative, green).
ab150375 has not yet been referenced specifically in any publications.